Preview Mode Links will not work in preview mode

Medscape InDiscussion: Schizophrenia

Dec 7, 2022

Drs John Kane and Jose Rubio-Lorente discuss relapse in schizophrenia — why it occurs, how often it occurs, and what we can do about it.

Relevant disclosures can be found with the episode show notes on Medscape ( The topics and discussions are planned, produced, and reviewed independently of advertiser. This podcast is intended only for US healthcare professionals.



Schizophrenia Clinical Presentation

Natural Course of Schizophrenic Disorders: A 15-Year Follow-up of a Dutch Incidence Cohort

Predictors of Relapse Following Response From a First Episode of Schizophrenia or Schizoaffective Disorder

Five-Fold Increased Risk of Relapse Following Breaks in Antipsychotic Treatment of First Episode Psychosis

Long-term Continuity of Antipsychotic Treatment for Schizophrenia: A Nationwide Study

Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29,823 Patients With Schizophrenia

Long-Acting Injectable Versus Oral Antipsychotics for the Maintenance Treatment of Schizophrenia: A Systematic Review and Comparative Meta-analysis of Randomised, Cohort, and Pre-Post Studies

Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia: A Randomized Clinical Trial

Psychosis Relapse During Treatment With Long-Acting Injectable Antipsychotics in Individuals With Schizophrenia-Spectrum Disorders: An Individual Participant Data Meta-analysis

The Pharmacological Treatment of Schizophrenia: How Far Have We Come?

Striatal Functional Connectivity in Psychosis Relapse: A Hypothesis Generating Study